Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study
R. José, Ali O. Mohammed, J. Goldring, R. Chambers, Jeremy S. Brown, B. Agarwal
{"title":"Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study","authors":"R. José, Ali O. Mohammed, J. Goldring, R. Chambers, Jeremy S. Brown, B. Agarwal","doi":"10.15172/pneu.2015.6/645","DOIUrl":null,"url":null,"abstract":"Patients with community-acquired pneumonia (CAP) and an underlying diagnosis of cancer have worse outcomes. However, the characteristics of cancer patients with CAP admitted to intensive care units (ICUs) are not well established. In a retrospective observational study, patients admitted to a London university hospital ICU between January 2006 and October 2011 with a primary diagnosis of CAP were included. Demographic, clinical, laboratory, and outcome data were collected from the ICU and hospital pathology databases. The analysis included 96 patients with CAP, 19 of whom had an existing diagnosis of cancer. Patients with cancer had a longer median time interval between hospital and ICU admission (1 vs 2 days, p = 0.049). On admission to ICU, there were no differences in white cell count, C-reactive protein, clotting, renal function, liver function, heart rate, temperature, systolic blood pressure or oxygenation index between patients with or without cancer. However, patients with cancer had significantly lower haemoglobin levels (median 8.6 vs 10.0 g/dl, p = 0.010) and lowest diastolic blood pressure (median 40 vs 50 mmHg, p = 0.026), and higher sodium levels (median 142 vs 139 mmol/l), p = 0.020), APACHE II (median 25 vs 20, p = 0.009), SAPS II (median 51 vs 43, p = 0.039) and SOFA (median 12 vs 9, p = 0.018) scores. There were no statistically significant differences in the proportion of patients receiving mechanical ventilation or renal support, the duration of mechanical ventilation or ICU or hospital length of stay. Patients with cancer were more likely to receive vasopressors (89.5% vs 63.6%, p = 0.030) and had increased ICU (68.4% vs 31.2%, p = 0.004) and hospital (78.9% vs 33.8%, p = 0.001) mortality. The limitations of this study are its relatively small sample size and those associated with the retrospective study design. In conclusion, cancer patients with CAP had an increased risk of death that was associated with increased illness severity and prevalence of septic shock at the time of ICU admission, suggesting there may be a delay in recognition for the need for intensive care support in these patients.","PeriodicalId":45120,"journal":{"name":"Pneumonia","volume":"6 1","pages":"77 - 82"},"PeriodicalIF":8.5000,"publicationDate":"2015-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.15172/pneu.2015.6/645","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumonia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15172/pneu.2015.6/645","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 2
Abstract
Patients with community-acquired pneumonia (CAP) and an underlying diagnosis of cancer have worse outcomes. However, the characteristics of cancer patients with CAP admitted to intensive care units (ICUs) are not well established. In a retrospective observational study, patients admitted to a London university hospital ICU between January 2006 and October 2011 with a primary diagnosis of CAP were included. Demographic, clinical, laboratory, and outcome data were collected from the ICU and hospital pathology databases. The analysis included 96 patients with CAP, 19 of whom had an existing diagnosis of cancer. Patients with cancer had a longer median time interval between hospital and ICU admission (1 vs 2 days, p = 0.049). On admission to ICU, there were no differences in white cell count, C-reactive protein, clotting, renal function, liver function, heart rate, temperature, systolic blood pressure or oxygenation index between patients with or without cancer. However, patients with cancer had significantly lower haemoglobin levels (median 8.6 vs 10.0 g/dl, p = 0.010) and lowest diastolic blood pressure (median 40 vs 50 mmHg, p = 0.026), and higher sodium levels (median 142 vs 139 mmol/l), p = 0.020), APACHE II (median 25 vs 20, p = 0.009), SAPS II (median 51 vs 43, p = 0.039) and SOFA (median 12 vs 9, p = 0.018) scores. There were no statistically significant differences in the proportion of patients receiving mechanical ventilation or renal support, the duration of mechanical ventilation or ICU or hospital length of stay. Patients with cancer were more likely to receive vasopressors (89.5% vs 63.6%, p = 0.030) and had increased ICU (68.4% vs 31.2%, p = 0.004) and hospital (78.9% vs 33.8%, p = 0.001) mortality. The limitations of this study are its relatively small sample size and those associated with the retrospective study design. In conclusion, cancer patients with CAP had an increased risk of death that was associated with increased illness severity and prevalence of septic shock at the time of ICU admission, suggesting there may be a delay in recognition for the need for intensive care support in these patients.
社区获得性肺炎(CAP)和潜在癌症诊断的患者预后更差。然而,重症监护病房(icu)的CAP癌症患者的特征尚未得到很好的确定。在一项回顾性观察性研究中,纳入了2006年1月至2011年10月期间伦敦大学医院ICU收治的初步诊断为CAP的患者。人口统计学、临床、实验室和结局数据收集自ICU和医院病理数据库。该分析包括96名CAP患者,其中19人已有癌症诊断。癌症患者住院至ICU住院的中位时间间隔较长(1天vs 2天,p = 0.049)。入ICU时,有无肿瘤患者白细胞计数、c反应蛋白、凝血、肾功能、肝功能、心率、体温、收缩压、氧合指数均无差异。然而,癌症患者的血红蛋白水平显著降低(中位数8.6 vs 10.0 g/dl, p = 0.010),舒张压最低(中位数40 vs 50 mmHg, p = 0.026),钠水平较高(中位数142 vs 139 mmol/l), APACHE II(中位数25 vs 20, p = 0.009), SAPS II(中位数51 vs 43, p = 0.039)和SOFA(中位数12 vs 9, p = 0.018)评分。两组患者接受机械通气或肾支持的比例、机械通气持续时间、ICU或住院时间差异均无统计学意义。癌症患者更容易接受血管加压药物治疗(89.5%比63.6%,p = 0.030), ICU(68.4%比31.2%,p = 0.004)和医院(78.9%比33.8%,p = 0.001)死亡率增加。本研究的局限性在于样本量相对较小,且与回顾性研究设计有关。综上所述,CAP癌症患者的死亡风险增加,这与ICU入院时疾病严重程度和感染性休克患病率的增加有关,表明这些患者对重症监护支持需求的认识可能存在延迟。